K56T (p.Lys56Thr) variant of GCK (Hexokinase-4)

K56T (p.Lys56Thr) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Monogenic diabetes. The available variant effect predictions contribute to a CATVariant prioritization score of 0.64 / 1. The record also includes structural context.

K56T (p.Lys56Thr) variant details